Factors associated with long term survival: univariate analysis
| No death (n=93) | Death (n=119) | p Value | |
|---|---|---|---|
| Data are n (%) unless otherwise indicated. | |||
| Mean (SD) age (years) | 45 (17) | 59 (50) | <0.001 |
| Male sex | 70 (75) | 90 (76) | NS |
| Cardiac and non-cardiac risk factors | 70 (75) | 103 (87) | <0.04 |
| Cardiac risk factors | 60 (65) | 73 (61) | NS |
| Pre-existing valvar heart disease | 44 (47) | 48 (40) | NS |
| Pre-existing prosthetic valve | 12 (13) | 24 (20) | NS |
| Congenital heart disease | 6 (6) | 2 (2) | NS |
| Non-cardiac risk factors | 21 (23) | 64 (54) | <0.001 |
| Injected drug use | 9 (10) | 13 (11) | NS |
| Renal insufficiency | 10 (11) | 27 (23) | <0.02 |
| Diabetes mellitus | 8 (9) | 19 (16) | NS |
| Cancer | 3 (3) | 19 (16) | <0.003 |
| Mean (SD) symptoms/signs on admission | 6 (2) | 5 (2) | <0.05 |
| Symptoms/signs during endocarditis | |||
| Fatigue | 71 (76) | 68 (57) | <0.004 |
| Arthralgia | 34 (37) | 20 (17) | <0.001 |
| Congestive heart failure | 31 (33) | 57 (48) | <0.03 |
| Peripheral arterial embolism | 38 (41) | 33 (28) | <0.04 |
| Cough | 52 (56) | 44 (37) | <0.006 |
| Vascular phenomena | 57 (61) | 56 (47) | <0.04 |
| Mean (SD) C reactive protein (mg/l) | 83 (60) | 140 (80) | <0.001 |
| MT patients | 48 (52) | 83 (70) | <0.02 |
| Late valve surgery | 5 (5) | 11 (9) | NS |
| MST patients | 45 (48) | 36 (30) | <0.02 |
| Valve surgery during follow up | 2 (2) | 3 (3) | NS |
| Anticoagulant treatment endocarditis | 59 (63) | 65 (55) | NS |
| Causative organisms: staphylococci | 29 (31) | 47 (39) | NS |
| Causative organisms: streptococci | 53 (57) | 49 (41) | NS |